<DOC>
	<DOCNO>NCT01717924</DOCNO>
	<brief_summary>The ADCI 002 trial large multicenter phase II-III prospective randomize control trial compare primary surgery versus primary chemotherapy follow surgery patient resectable signet ring cell gastric adenocarcinoma</brief_summary>
	<brief_title>Evaluation Surgery Versus Primary Chemotherapy Resectable Signet Ring Cell Gastric Adenocarcinoma</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<criteria>adenocarcinoma stomach oesogastric junction type III Siewert classification , histologically proven presence signet ring cell ( accord WHO 2000 classification ) diffuse form ( accord Lauren classification ) pretherapeutic biopsy tumoural stage IB , II III ( accord UICCAJCC 2009 ) patient judge resectable curative intent inclusion absence distant metastasis absence peritoneal carcinomatosis pretreatment explorative laparoscopy WHO performance status 2 less age 18 80 year weight loss time inclusion &lt; 15 % neutrophilic polynuclears 1500/mm3 platelet 100000/mm3 creatinine clearance 50 ml/min serumalbumin 30 gram/l bilirubin le 1,5 normal prothrombin rate 80 % absence prior treatment chemotherapy radiotherapy gastric cancer absence kniwn child B C cirrhosis leave ventricular ejection fraction 50 % epirubicin treatment extension checkup perform within 4 week inclusion sign write informed consent give patient correspond inclusion criterion another malignant tumour treat curative purpose past 5 year except basocellular skin carcinoma situ uterine cervix cancer allergy active substance one excipients study drug pregnancy breastfeed concommitant treatment , immunotherapy hormonal therapy history abdominal chest radiotherapy evolve disorder control ( liver failure , kidney failure , respiratory failure , evolve heart failure myocardial necrosis past 6 month ) patient regularly monitor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Signet ring cell</keyword>
	<keyword>gastric adenocarcinoma</keyword>
	<keyword>peri-operative chemotherapy</keyword>
	<keyword>surgery</keyword>
</DOC>